DLPIC
INSM icon

Davide Leone & Partners Investment Company’s Insmed INSM Stock Holding History

Davide Leone & Partners Investment Company’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-21,995
Closed -$749K – 88
2021
Q1 		$749K Buy
+21,995
New +$841K 0.09% 95

Other funds holding INSM

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Davide Leone & Partners Investment Company's INSM Position: Q2 2021 in Review

Davide Leone & Partners Investment Company sold out of Insmed (INSM) in Q2 2021, closing a stake of 21,995 shares — an estimated $749K sold.

Davide Leone & Partners Investment Company first reported a position in INSM in Q1 2021 and held it in 1 quarter. The position peaked at $749K in Q1 2021. 202 funds tracked by Wall St. Rank hold INSM as of Q2 2021.

  • Davide Leone & Partners Investment Company reported no remaining Insmed position as of Q2 2021 after selling out during the quarter.
  • Davide Leone & Partners Investment Company sold 21,995 Insmed shares in Q2 2021, an estimated $749K.
  • Davide Leone & Partners Investment Company first reported a position in Insmed in Q1 2021 and held it in 1 quarter.
  • Davide Leone & Partners Investment Company's Insmed position peaked at $749K in Q1 2021.
  • 202 funds tracked by Wall St. Rank held Insmed as of Q2 2021.

Based on Davide Leone & Partners Investment Company's 13F filing for Q2 2021, filed 16 Aug 2021.